|
Market Closed -
Bombay S.E.
11:02:30 01/10/2026 BST
|
5-day change | 1st Jan Change | ||
| 10.33 INR | -0.19% |
|
-6.43% | -47.03% |
| Market Cap | 1.99B 20.64M 18.33M 17.14M 15.62M 29.41M 29.82M 207M 80.29M 1.01B 77.5M 75.82M 3.25B | P/E 2025 |
-4.53x | P/E 2026 | -0.69x |
|---|---|---|---|---|---|
| Enterprise Value | 736M 7.65M 6.79M 6.35M 5.79M 10.9M 11.05M 76.84M 29.74M 375M 28.71M 28.09M 1.2B | EV / Sales 2025 |
0.64x | EV / Sales 2026 | - |
| Free-Float |
44.34% | Yield 2025 * |
-
| Yield 2026 | - |
Bombay S.E.INR
| Markets | Quality | ||
|---|---|---|---|
NSE India S.E.
| NECLIFE | Delayed | |
Bombay S.E.
| NECLIFE | Delayed |
| 1 day | -0.19% | ||
| 1 week | -6.43% | ||
| Current month | -0.19% | ||
| 1 month | -17.29% | ||
| 3 months | -11.33% | ||
| 6 months | +10.96% | ||
| Current year | -47.03% |
| 1 week | 10.18 | 11.19 | |
| 1 month | 10.18 | 12.72 | |
| Current year | 9.2 | 20.94 | |
| 1 year | 9.2 | 22.49 | |
| 3 years | 9.2 | 56.39 | |
| 5 years | 9.2 | 56.39 | |
| 10 years | 7.2 | 56.39 |
| Manager | Title | Age | Since |
|---|---|---|---|
Sushil Kapoor
DFI | Director of Finance/CFO | 68 | 13/11/2022 |
| Compliance Officer | - | 31/03/2025 |
| Director | Title | Age | Since |
|---|---|---|---|
Sanjiv Goyal
CHM | Chairman | 66 | 26/06/1995 |
Rupinder Tewari
BRD | Director/Board Member | 69 | 10/02/2019 |
| Director/Board Member | 75 | 20/09/2021 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -0.19% | -6.43% | - | - | 21.27M | ||
| -0.31% | -2.86% | +39.10% | +113.29% | 1,031B | ||
| -1.99% | -4.09% | +39.54% | +67.34% | 638B | ||
| -0.44% | -1.70% | +6.64% | +75.79% | 462B | ||
| -1.08% | -2.90% | +59.43% | +40.12% | 359B | ||
| -0.03% | -3.96% | +23.63% | +40.70% | 335B | ||
| -1.58% | -0.76% | +13.50% | +26.44% | 273B | ||
| -2.02% | -2.97% | -3.25% | +9.88% | 253B | ||
| -2.40% | +1.41% | +37.95% | +54.62% | 228B | ||
| -0.73% | -1.20% | +33.05% | +99.58% | 185B | ||
| Average | -1.12% | -0.36% | +27.73% | +58.64% | 418.21B | |
| Weighted average by Cap. | -1.09% | -0.35% | +30.68% | +69.99% |
| 2025 | 2026 | |
|---|---|---|
| Net sales | 16.7B 173M 154M 144M 131M 247M 251M 1.74B 675M 8.51B 651M 637M 27.32B | - |
| Net income | -1.14B -11.81M -10.49M -9.81M -8.94M -16.83M -17.06M -119M -45.93M -579M -44.33M -43.37M -1.86B | -2.93B -30.42M -27.02M -25.27M -23.03M -43.35M -43.95M -306M -118M -1.49B -114M -112M -4.79B |
| Net Debt | 5.62B 58.4M 51.87M 48.51M 44.2M 83.22M 84.36M 587M 227M 2.86B 219M 215M 9.2B | -1.25B -12.99M -11.54M -10.79M -9.84M -18.52M -18.77M -131M -50.54M -637M -48.79M -47.73M -2.05B |
Employees
111
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 01/10/26 | ₹10.33 | -0.19% | 3,138 |
| 30/09/26 | ₹10.35 | -3.36% | 47,012 |
| 29/09/26 | ₹10.71 | -0.37% | 15,661 |
| 28/09/26 | ₹10.75 | -0.19% | 5,263 |
| 25/09/26 | ₹10.77 | -1.10% | 24,469 |
- Stock Market
- Stocks
- NECLIFE Stock
- NECLIFE Stock
Select your edition
All financial news and data tailored to specific country editions

















